Oncolytic Virus Therapy-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Oncolytic Virus Therapy

• 1.1 Definition of Oncolytic Virus Therapy in This Report
• 1.2 Commercial Types of Oncolytic Virus Therapy
  • 1.2.1 HSV-based Oncolytic Viruses
  • 1.2.2 Adenoviruses-based Oncolytic Viruses
  • 1.2.3 Vaccinia Virus-based Oncolytic Viruses
  • 1.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
  • 1.2.5 Newcastle Disease Virus-based Oncolytic Viruses
• 1.3 Downstream Application of Oncolytic Virus Therapy
  • 1.3.1 Melanoma
  • 1.3.2 Prostate Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Ovarian Cancer
  • 1.3.5 Others
• 1.4 Development History of Oncolytic Virus Therapy
• 1.5 Market Status and Trend of Oncolytic Virus Therapy 2016-2026
  • 1.5.1 Global Oncolytic Virus Therapy Market Status and Trend 2016-2026
  • 1.5.2 Regional Oncolytic Virus Therapy Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Oncolytic Virus Therapy 2016-2021
• 2.2 Production Market of Oncolytic Virus Therapy by Regions
  • 2.2.1 Production Volume of Oncolytic Virus Therapy by Regions
  • 2.2.2 Production Value of Oncolytic Virus Therapy by Regions
• 2.3 Demand Market of Oncolytic Virus Therapy by Regions
• 2.4 Production and Demand Status of Oncolytic Virus Therapy by Regions
  • 2.4.1 Production and Demand Status of Oncolytic Virus Therapy by Regions 2016-2021
  • 2.4.2 Import and Export Status of Oncolytic Virus Therapy by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Oncolytic Virus Therapy by Types
• 3.2 Production Value of Oncolytic Virus Therapy by Types
• 3.3 Market Forecast of Oncolytic Virus Therapy by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Oncolytic Virus Therapy by Downstream Industry
• 4.2 Market Forecast of Oncolytic Virus Therapy by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Oncolytic Virus Therapy

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Oncolytic Virus Therapy Downstream Industry Situation and Trend Overview

Chapter 6 Oncolytic Virus Therapy Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Oncolytic Virus Therapy by Major Manufacturers
• 6.2 Production Value of Oncolytic Virus Therapy by Major Manufacturers
• 6.3 Basic Information of Oncolytic Virus Therapy by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Oncolytic Virus Therapy Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Oncolytic Virus Therapy Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Oncolytic Virus Therapy Major Manufacturers Introduction and Market Data

• 7.1 Amgen
  • 7.1.1 Company profile
  • 7.1.2 Representative Oncolytic Virus Therapy Product
  • 7.1.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Amgen
• 7.2 Oncolytics Biotech
  • 7.2.1 Company profile
  • 7.2.2 Representative Oncolytic Virus Therapy Product
  • 7.2.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Oncolytics Biotech
• 7.3 Viralytics
  • 7.3.1 Company profile
  • 7.3.2 Representative Oncolytic Virus Therapy Product
  • 7.3.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Viralytics
• 7.4 Transgene SA
  • 7.4.1 Company profile
  • 7.4.2 Representative Oncolytic Virus Therapy Product
  • 7.4.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Transgene SA
• 7.5 Oncolys BioPharma
  • 7.5.1 Company profile
  • 7.5.2 Representative Oncolytic Virus Therapy Product
  • 7.5.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Oncolys BioPharma
• 7.6 Targovax
  • 7.6.1 Company profile
  • 7.6.2 Representative Oncolytic Virus Therapy Product
  • 7.6.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Targovax
• 7.7 PsiOxus Therapeutics
  • 7.7.1 Company profile
  • 7.7.2 Representative Oncolytic Virus Therapy Product
  • 7.7.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of PsiOxus Therapeutics
• 7.8 SillaJen Biotherapeutics
  • 7.8.1 Company profile
  • 7.8.2 Representative Oncolytic Virus Therapy Product
  • 7.8.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of SillaJen Biotherapeutics
• 7.9 Sorrento Therapeutics
  • 7.9.1 Company profile
  • 7.9.2 Representative Oncolytic Virus Therapy Product
  • 7.9.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics
• 7.10 Lokon Pharma
  • 7.10.1 Company profile
  • 7.10.2 Representative Oncolytic Virus Therapy Product
  • 7.10.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Lokon Pharma
• 7.11 Genelux Corporation
  • 7.11.1 Company profile
  • 7.11.2 Representative Oncolytic Virus Therapy Product
  • 7.11.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Genelux Corporation
• 7.12 Vyriad
  • 7.12.1 Company profile
  • 7.12.2 Representative Oncolytic Virus Therapy Product
  • 7.12.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Vyriad
• 7.13 TILT Biotherapeutics
  • 7.13.1 Company profile
  • 7.13.2 Representative Oncolytic Virus Therapy Product
  • 7.13.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of TILT Biotherapeutics
• 7.14 Cold Genesys
  • 7.14.1 Company profile
  • 7.14.2 Representative Oncolytic Virus Therapy Product
  • 7.14.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Cold Genesys

Chapter 8 Upstream and Downstream Market Analysis of Oncolytic Virus Therapy

• 8.1 Industry Chain of Oncolytic Virus Therapy
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Oncolytic Virus Therapy

• 9.1 Cost Structure Analysis of Oncolytic Virus Therapy
• 9.2 Raw Materials Cost Analysis of Oncolytic Virus Therapy
• 9.3 Labor Cost Analysis of Oncolytic Virus Therapy
• 9.4 Manufacturing Expenses Analysis of Oncolytic Virus Therapy

Chapter 10 Marketing Status Analysis of Oncolytic Virus Therapy

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources